Corpus ID: 13926853

Studies on Drug Interactions between CYP 3 A 4 Inhibitors and Glucocorticoids by

@inproceedings{Varis2000StudiesOD,
  title={Studies on Drug Interactions between CYP 3 A 4 Inhibitors and Glucocorticoids by},
  author={T. Varis},
  year={2000}
}
  • T. Varis
  • Published 2000
  • ............................................................................................................................8 INTRODUCTION ...................................................................................................................9 REVIEW OF THE LITERATURE......................................................................................10 1. Drug metabolism.............................................................................................................10… CONTINUE READING

    References

    SHOWING 1-10 OF 197 REFERENCES
    The effects of diltiazem on hepatic drug metabolizing enzymes in man using antipyrine, trimethadione and debrisoquine as model substrates.
    • 6
    Mibefradil is a P-glycoprotein substrate and a potent inhibitor of both P-glycoprotein and CYP3A in vitro.
    • 65
    Effects of the Antifungal Agents on Oxidative Drug Metabolism
    • 469
    Modulation and prevention of multidrug resistance by inhibitors of P-glycoprotein
    • 280
    The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.
    • 323
    Inhibition and Induction of Cytochrome P450 and the Clinical Implications
    • J. Lin, A. Lu
    • Biology, Medicine
    • Clinical pharmacokinetics
    • 1998
    • 754
    • Highly Influential
    • PDF
    Different effects of itraconazole on the pharmacokinetics of fluvastatin and lovastatin.
    • 154